Standout Papers

Production of vascular endothelial growth factor by human tumors inhibits the functional matur... 1996 2026 2006 2016 1.5k
  1. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells (1996)
    Dmitry I. Gabrilovich, Geralyn M. Meny et al. Nature Medicine
  2. Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer (2001)
    Bond Almand, Joseph I. Clark et al. The Journal of Immunology
  3. Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis (2004)
    Yang Li, Laura M. DeBusk et al. Cancer Cell
  4. Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo (1998)
    Dmitry I. Gabrilovich, Tadao Ishida et al. Blood
  5. Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis (2008)
    Li Yang, Jianhua Huang et al. Cancer Cell
  6. Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo (1998)
    Dmitry I. Gabrilovich, Tadao Ishida et al. Blood
  7. Non-small-cell lung cancer (2015)
    Cesare Gridelli, Antônio Rossi et al. Nature Reviews Disease Primers
  8. Clinical significance of defective dendritic cell differentiation in cancer. (2000)
    Bond Almand, Brian R. Lindman et al. PubMed
  9. NKT cell–mediated repression of tumor immunosurveillance by IL-13 and the IL-4R–STAT6 pathway (2000)
    Masaki Terabe, So Matsui et al. Nature Immunology
  10. PDL1 Regulation by p53 via miR-34 (2015)
    María Angélica Cortez, Cristina Ivan et al. JNCI Journal of the National Cancer Institute
  11. Targeting KRAS in non-small-cell lung cancer: recent progress and new approaches (2021)
    Martin Reck, David P. Carbone et al. Annals of Oncology

Immediate Impact

8 by Nobel laureates 20 from Science/Nature 136 standout
Sub-graph 1 of 17

Citing Papers

Evaluating eligibility criteria of oncology trials using real-world data and AI
2021 StandoutNature
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout

Works of David P. Carbone being referenced

VEGF as a Mediator of Tumor-Associated Immunodeficiency
2001
Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo
1998 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
David P. Carbone 13377 6418 10758 8966 408 26.4k
Catherine Sautès‐Fridman 14429 5056 8164 15615 300 28.2k
Jeffrey A. Sosman 15916 8198 15337 6817 343 28.0k
Jennifer A. Wargo 15446 3516 11019 8004 260 24.6k
Silvia C. Formenti 15199 6295 4992 9581 346 26.4k
Paolo A. Ascierto 17638 3392 11139 6919 744 24.4k
Georgina V. Long 24765 5086 16231 8971 669 33.3k
Timothy A. Chan 10078 5373 9193 4421 241 22.0k
Dave S.�B. Hoon 9397 2791 10873 5683 401 21.1k
Grant A. McArthur 14701 5248 14988 3713 388 26.3k
John Nemunaitis 13692 4895 9640 5907 538 24.9k

All Works

Loading papers...

Rankless by CCL
2026